Danaher Officer Files Form 144 for Stock Sale
Danaher Corporation officer Matthew McGrew filed a Form 144 to propose the sale of 29,754 shares of common stock.
Stocks · News reference
Genedata, a Danaher company, has introduced an electronic lab notebook (ELN) that integrates directly into its existing biopharmaceutical R&D platform.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Danaher Corporation officer Matthew McGrew filed a Form 144 to propose the sale of 29,754 shares of common stock.
Evercore ISI has revised its price target for Danaher Corporation, lowering it from $242 to $205.
Danaher (DHR) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates. The industrial and medical device maker's consensus estimate for fiscal year 2026 shows a 0.8% increase over the past three months. The upgrade positions Danaher in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.